Instead of searching for highly specific RING domain inhibitors with limited cancer cell killing effect, we decided to identify leads with pro-apoptotic activity in p53-mutant cells among MMRi hit analogues and consequently we identified MMRi36 leading to development of MMRi36C5. The gene discussed is TP53; the disease is cancer.